Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm Read more about Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial Read more about Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial
IMpella-Protected cArdiaC Surgery Trial (IMPACT) Read more about IMpella-Protected cArdiaC Surgery Trial (IMPACT)
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in NMIBC Read more about A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in NMIBC
A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET Read more about A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET
A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV Read more about A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV
Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura Read more about Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis Read more about Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis
A Study to Investigate LYL797 in Adults With Solid Tumors Read more about A Study to Investigate LYL797 in Adults With Solid Tumors
A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera Read more about A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera